Jefferies on Alkem Labs Buy, TP Rs 6550

 19 Feb 2026 08:23 AM

Jefferies on Alkem Labs Buy, TP Rs 6550

Alkem Lab: USFDA Finishes Pre-Approval Inspection At Enzene Biosciences; Issues 6 Procedural Observations But Confirms No Data Integrity Issues.

 16 Feb 2026 03:02 PM

Alkem Lab: USFDA Finishes Pre-Approval Inspection At Enzene Biosciences; Issues 6 Procedural Observations But Confirms No Data Integrity Issues.

Alkem Laboratories: Reports 5.5% Growth In Indian Business For Q3, Falling Short Of H2FY26 Target Of Double Digit Growth.

 13 Feb 2026 02:19 PM

Alkem Laboratories: Reports 5.5% Growth In Indian Business For Q3, Falling Short Of H2FY26 Target Of Double Digit Growth.

ALKEM LABORATORIES LTD: CO. TO ACQUIRE 51%-55% STAKE IN OCCLUTECH HOLDING AG FOR CASH CONSIDERATION; TARGET ENTITY ENGAGED IN MINIMALLY INVASIVE CARDIAC IMPLANTS; ACQUISITION EXPECTED TO BE COMPLETED BY JUNE 30, 2026.

 13 Feb 2026 02:04 PM

ALKEM LABORATORIES LTD: CO. TO ACQUIRE 51%-55% STAKE IN OCCLUTECH HOLDING AG FOR CASH CONSIDERATION; TARGET ENTITY ENGAGED IN MINIMALLY INVASIVE CARDIAC IMPLANTS; ACQUISITION EXPECTED TO BE COMPLETED BY JUNE 30, 2026.

Alkem Laboratories: To Buy 51%-55% Share In Occlutech Holding AG For €180.70 Million; Deal Expected To Close By June 30, 2026; Occlutech Specializes In Minimally Invasive Cardiac Implants With Revenue Of €49.38 Million In 2025.

 13 Feb 2026 02:11 PM

Alkem Laboratories: To Buy 51%-55% Share In Occlutech Holding AG For €180.70 Million; Deal Expected To Close By June 30, 2026; Occlutech Specializes In Minimally Invasive Cardiac Implants With Revenue Of €49.38 Million In 2025.

ALKEM LABORATORIES: Q3 CONS NET PROFIT 6.4B RUPEES VS 6.3B (YOY); EST 6.7B

 13 Feb 2026 01:51 PM

ALKEM LABORATORIES: Q3 CONS NET PROFIT 6.4B RUPEES VS 6.3B (YOY); EST 6.7B

ALKEM LABORATORIES: Q3 REVENUE 37.4B RUPEES VS 34B (YOY)

 13 Feb 2026 01:51 PM

ALKEM LABORATORIES: Q3 REVENUE 37.4B RUPEES VS 34B (YOY)

ALKEM LAB: CO DECLARED DIVIDEND OF 43 RUPEES PER SHARE

 13 Feb 2026 01:51 PM

ALKEM LAB: CO DECLARED DIVIDEND OF 43 RUPEES PER SHARE

ALKEM LABORATORIES: Q3 EBITDA 8.3B RUPEES VS 7.6B (YOY) || Q3 EBITDA MARGIN 22.2% VS 22.51% (YOY)

 13 Feb 2026 01:52 PM

ALKEM LABORATORIES: Q3 EBITDA 8.3B RUPEES VS 7.6B (YOY) || Q3 EBITDA MARGIN 22.2% VS 22.51% (YOY)

Alkem Laboratories: Board Supports Merging Alkem Medtech Ortho Private Limited With Alkem Medtech Private Limited, Awaiting NCLT Approval and Shareholder Consent.

 06 Feb 2026 01:57 PM

Alkem Laboratories: Board Supports Merging Alkem Medtech Ortho Private Limited With Alkem Medtech Private Limited, Awaiting NCLT Approval and Shareholder Consent.

Alkem Laboratories: Co To Consider Q3 Results On Feb 13

 23 Jan 2026 01:32 PM

Alkem Laboratories: Co To Consider Q3 Results On Feb 13

Alkem Laboratories: Introduces Renocia Cyclical Therapy, A Nutritional Supplement Kit For Hair Growth Aimed At Both Men And Women With Vegetarian Ingredients, Featuring A Weekly Plan For Better Nutrient Absorption.

 08 Jan 2026 03:03 PM

Alkem Laboratories: Introduces Renocia Cyclical Therapy, A Nutritional Supplement Kit For Hair Growth Aimed At Both Men And Women With Vegetarian Ingredients, Featuring A Weekly Plan For Better Nutrient Absorption.

Alkem Lab: Alkem Wellness Pays ₹32.5 Crore To Complete ₹532.5 Crore Sale Of Trade Generics Business

 30 Dec 2025 06:18 PM

Alkem Lab: Alkem Wellness Pays ₹32.5 Crore To Complete ₹532.5 Crore Sale Of Trade Generics Business

Alkem Labs: Announces Purchase of Shares in Enzene Biosciences for 3 Billion Rupees

 26 Dec 2025 07:15 PM

Alkem Labs: Announces Purchase of Shares in Enzene Biosciences for 3 Billion Rupees

Alkem Laboratories: Malta Medicines Authority Inspects Daman Facility With No Critical Issues Found; Three Major And Several Minor Observations Need Attention.

 10 Dec 2025 10:45 AM

Alkem Laboratories: Malta Medicines Authority Inspects Daman Facility With No Critical Issues Found; Three Major And Several Minor Observations Need Attention.

Alkem Labs: Health Ministry Inspects Sikkim, India Manufacturing Facility, Concludes With No Major Observations.

 24 Nov 2025 07:58 AM

Alkem Labs: Health Ministry Inspects Sikkim, India Manufacturing Facility, Concludes With No Major Observations.

Alkem Labs: HSBC on Alkem Labs Hold, target price raised to Rs 5170

 14 Nov 2025 08:58 AM

Alkem Labs: HSBC on Alkem Labs Hold, target price raised to Rs 5170

Alkem Labs: Nomura on Alkem Labs Buy, target price Rs 6860

 14 Nov 2025 08:58 AM

Alkem Labs: Nomura on Alkem Labs Buy, target price Rs 6860

ALKEM LABORATORIES: Q2 CONS NET PROFIT 7.7B RUPEES VS 6.9B (YOY)

 13 Nov 2025 01:49 PM

ALKEM LABORATORIES: Q2 CONS NET PROFIT 7.7B RUPEES VS 6.9B (YOY)

ALKEM LABORATORIES: Q2 EBITDA 9.1B RUPEES VS 7.5B (YOY) || Q2 EBITDA MARGIN 22.8% VS 22.04% (YOY)

 13 Nov 2025 01:49 PM

ALKEM LABORATORIES: Q2 EBITDA 9.1B RUPEES VS 7.5B (YOY) || Q2 EBITDA MARGIN 22.8% VS 22.04% (YOY)